Home
Discover
Research
Finance
Strategy

Get 40% off Premium. Unlock the BEST of AlphaPilot.

Finance
LUMO

Overview Financials Analysis Smart Money

Lumos Pharma, Inc.

LUMO · NASDAQ

Analyze with AI

Filings1

Total reported value$178.4K

Manager	Shares	Value	Change
BlackRock Inc.	41.1K	$178.4K	0.0%

SymbolLUMO

Market Cap$37.5M

IPO Date2011-11-11

CEORichard J. Hawkins

Employees30

SectorHealthcare

IndustryBiotechnology

CountryUS

ExchangeNASDAQ Global Market

Mega Fortune Company Limited

MGRT

$13.05

+143.93%

Processa Pharmaceuticals, Inc.

PCSA

$6.68

+122.30%

cbdMD, Inc.

YCBD

$2.27

+58.74%

Agape ATP Corporation

ATPC

$0.1408

+56.44%

VYNE Therapeutics Inc.

VYNE

$0.60

+48.99%

Peers

Satsuma Pharmaceuticals, Inc.

STSA · NASDAQ

$1.10

+0.00%

Eyenovia, Inc.

EYEN · NASDAQ

$7.56

+3.99%

Pluristem Therapeutics Inc.

PSTI · NASDAQ

$1.00

-2.91%

Cerecor Inc.

CERC · NASDAQ

$2.93

-1.68%

LianBio

LIANY · OTC

$0.10

+7.53%

Magenta Therapeutics, Inc.

MGTA · NASDAQ

$0.6996

-7.74%

Grace Therapeutics, Inc.

GRCE · NASDAQ

$3.35

+0.30%

Lunai Bioworks Inc.

RENB · NASDAQ

$1.42

+0.00%

Oruka Therapeutics, Inc.

ORKA · NASDAQ

$28.38

-1.94%

Opus Genetics, Inc.

IRD · NASDAQ

$2.02

-5.61%

Home

Home
Research
Strategy
Signal
Discover

Education

Academy
Tutorial
Strategy
Agent
Finance

Resources

Pricing
Referral
Partners
FAQ

Other

Terms
Privacy

Disclaimer: Content on AlphaPilot is for informational purposes only and does not constitute financial or investment advice. Past performance, including backtested results, is not indicative of future outcomes. AlphaPilot makes no guarantees regarding accuracy or reliability; use at your own risk.